ArticleOncotarget2016
Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer.
Dong Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
this papercites it
ArticleOncotarget2016
Dong Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.